Literature DB >> 401776

Cytochalasin B reversibly increases outflow facility in the eye of the cynomolgus monkey.

P L Kaufman, E H Bárány.   

Abstract

In cynomolgus monkeys, intracameral infusion of 0.2 to 5.0 mug of cytochalasin B caused an increase in outflow facility, as measured by two-level constant pressure perfusion. Cytochalasin B had its full effect in eyes which had undergone surgical disinsertion of the ciliary muscle from the scleral spur, and were therefore insensitive to pilocarpine. The cytochalasin effect was apparent in less than 20 min. and was largely reversible over a few hours. Thirty to 50 days after the infusion, facility was normal, and a second reaction could be elicited. No early or late damage to anterior segment structures was apparent by routine biomicroscopy during or after the single administration.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 401776

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

Review 1.  Enhancing trabecular outflow by disrupting the actin cytoskeleton, increasing uveoscleral outflow with prostaglandins, and understanding the pathophysiology of presbyopia interrogating Mother Nature: asking why, asking how, recognizing the signs, following the trail.

Authors:  Paul L Kaufman
Journal:  Exp Eye Res       Date:  2007-10-26       Impact factor: 3.467

2.  Microfilaments in the cells of the human trabecular meshwork.

Authors:  I Grierson; A H Rahi
Journal:  Br J Ophthalmol       Date:  1979-01       Impact factor: 4.638

Review 3.  Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma.

Authors:  Megumi Honjo; Hidenobu Tanihara
Journal:  Jpn J Ophthalmol       Date:  2018-02-14       Impact factor: 2.447

Review 4.  Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research.

Authors:  Ponugoti Vasantha Rao; Padmanabhan P Pattabiraman; Casey Kopczynski
Journal:  Exp Eye Res       Date:  2016-09-01       Impact factor: 3.467

Review 5.  The Pathway From Genes to Gene Therapy in Glaucoma: A Review of Possibilities for Using Genes as Glaucoma Drugs.

Authors:  Teresa Borrás
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2017 Jan-Feb

6.  Directed therapy for exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Open Ophthalmol J       Date:  2009-09-17

7.  Directed Therapy: An Approach to the Improved Treatment of Exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Middle East Afr J Ophthalmol       Date:  2009-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.